Progress in diagnosis and treatment of cardiac amyloidosis related arrhythmias
QIU Jia, LI Liwen
1. Department of Cardiology, Guangdong Provincial People’s Hospital; Guangdong Cardiovascular Institute; Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangzhou Guangdong 510100; 2. School of Medicine, South China University of Technology, Guangzhou Guangdong 510006, China
Abstract：Cardiac amyloidosis (CA) is manifested by restrictive cardiac dysfunction diseases resulted from deposition of extracellular protein fibrils in the myocardium. Various types of atrial arrhythmias and ventricular arrhythmias are common in CA patients. Sufficient evidencebased medical evidences with regard to the management of CA related arrhythmias are scarce at present. Therapeutic decision is mostly made according to clinical experience and expert consensus. Based on the latest references, and related expert consensus and guideline recommendations, this review covers the diagnosis and treatment of CA related arrhythmias.
丘嘉，黎励文. 心脏淀粉样变相关心律失常诊治进展[J]. 实用心电学杂志, 2021, 30(2): 77-81.
QIU Jia, LI Liwen. Progress in diagnosis and treatment of cardiac amyloidosis related arrhythmias. JOURNAL OF PRACTICAL ELECTROCARDIOLOGY, 2021, 30(2): 77-81.
